Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).
Clinical trial NCT04472429 · COMPLETED
Trial details
- NCT number
- NCT04472429
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-12
- Primary completion
- 2024-04-15
- Enrollment
- 308
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.